News Conference News ACC 2026 Hints of a Mortality Benefit With TTVR at 2 Years: TRISCEND II Yael L. Maxwell April 07, 2026
News Conference News ACC 2026 Sirolimus DCB in Peripheral Disease Makes Strides in Hard Outcomes: SirPAD L.A. McKeown April 02, 2026
News Conference News ACC 2026 Two Neutral IVUS Trials in Complex PCI—and One Positive—Spark Debate Todd Neale April 02, 2026
News Conference News ACC 2026 Olezarsen Doesn’t Lower Plaque Volume: Essence-TIMI 73b Yael L. Maxwell April 01, 2026
News Conference News ACC 2026 Oral PCSK9 Inhibitor Bests Other Nonstatin Therapies for LDL-Lowering Michael O'Riordan April 01, 2026
News Conference News ACC 2026 GoFreshRx, THRIVE Trials Show BP Benefits of ‘Food as Medicine’ L.A. McKeown March 31, 2026
News Conference News ACC 2026 Deferring PCI Until After TAVI Safe, Reduces Bleeding: PRO-TAVI Yael L. Maxwell March 30, 2026
News Conference News ACC 2026 CHAMPION-AF: A Win for Watchman FLX, but With Caveats Todd Neale March 28, 2026
News Conference News ACC 2026 Mechanical Circulatory Support Doesn’t Reduce Infarct Size in STEMI Michael O'Riordan March 28, 2026
News Conference News ACC 2025 ALPACA: Injectable siRNA Agent Safe and Effective for Lowering Lp(a) L.A. McKeown April 10, 2025
News Conference News ACC 2025 RACER: No Change in Cardiac Arrests During Marathons, but Survival Is Up Michael O'Riordan April 08, 2025
News Conference News ACC 2025 AI Shows Promise in Detecting Type 1 MI and Need for Revascularization Yael L. Maxwell April 07, 2025
News Conference News ACC 2025 DETECT-AS: Alert System Increases AV Replacement in Eligible Patients Michael O'Riordan April 04, 2025
News Conference News ACC 2025 FAIR-HF2: Another IV Iron Trial Fails to Impact Hard Endpoints L.A. McKeown April 03, 2025
News Conference News ACC 2025 Tight Fluid Restriction Not Needed in Chronic HF Patients: FRESH-UP Michael O'Riordan April 01, 2025
News Conference News ACC 2025 PCI Rebounds at 5 Years to Mostly Match CABG: Final FAME 3 Data Caitlin E. Cox March 31, 2025
News Conference News ACC 2025 By 2 Years, Tricuspid TEER Reduces Hospitalizations for HF: TRILUMINATE Michael O'Riordan March 31, 2025
News Conference News ACC 2025 Evolut Low Risk Trial: TAVI Holds Up to Surgery at 5 Years L.A. McKeown March 30, 2025
News Conference News ACC 2025 Dapagliflozin Works Well for High-Risk TAVI Patients With HF: DapaTAVI Caitlin E. Cox March 30, 2025